Hybridoma technology (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Hybridoma technology" in English language version.

refsWebsite

Global rank English rank

17nih.gov

4^th place

12doi.org

2^nd place

3semanticscholar.org

11^th place

8^th place

1worldcat.org

5^th place

doi.org

Milstein, C (1999). "The hybridoma revolution: an offshoot of basic research". BioEssays. 21 (11): 966–73. doi:10.1002/(SICI)1521-1878(199911)21:11<966::AID-BIES9>3.0.CO;2-Z. PMID 10517870.
Nelson, PN; Reynolds, GM; Waldron, EE; Ward, E; Giannopoulos, K; Murray, PG (2000). "Demystified ...: Monoclonal antibodies". Molecular Pathology. 53 (3): 111–7. doi:10.1136/mp.53.3.111. PMC 1186915. PMID 10897328.
Korbakis, D; Brinc, D; Schiza, C; Soosaipillai, A; Jarvi, K; Drabovich, AP; Diamandis, E (2015). "Immunocapture-selected reaction monitoring screening facilitates the development of ELISA for the measurement of native TEX101 in biological fluids". Molecular & Cellular Proteomics. 14 (6): 1517–1526. doi:10.1074/mcp.M114.047571. PMC 4458717. PMID 25813379.
Phung, Yen; Gao, Wei; Man, Yan-Gao; Nagata, Satoshi; Ho, Mitchell (September 2012). "High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening". mAbs. 4 (5): 592–599. doi:10.4161/mabs.20933. ISSN 1942-0870. PMC 3499300. PMID 22820551.
Bretton, PR; Melamed, MR; Fair, WR; Cote, RJ (1994). "Detection of occult micrometastases in the bone marrow of patients with prostate carcinoma". Prostate. 25 (2): 108–14. doi:10.1002/pros.2990250208. PMID 7518596. S2CID 32801503.
Kvalheim, G (1996). "Detection of occult tumor cells in bone marrow and blood in breast cancer patients—methods and clinical significance". Acta Oncol. 35: 13–18. doi:10.3109/02841869609098516. PMID 9073044.
Kvalheim, G (1998). "Diagnosis of minimal residual disease in bone marrow and blood in cancer patients--methods and clinical implications". Acta Oncologica. 37 (5): 455–62. doi:10.1080/028418698430403. PMID 9831374.
Franklin, WA; Shpall, EJ; Archer, P; Johnston, CS; Garza-Williams, S; Hami, L; Bitter, MA; Bast, RC; Jones, RB (1996). "Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support". Breast Cancer Res Treat. 41 (1): 1–13. doi:10.1007/BF01807031. PMID 8932871. S2CID 37415751.
Riesenberg, R; Oberneder, R; Kriegmair, M; Epp, M; Bitzer, U; Hofstetter, A; Braun, S; Riethmüller, G; Pantel, K (1993). "Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumour cells". Histochemistry. 99 (1): 61–6. doi:10.1007/BF00268022. PMID 7682210. S2CID 8007388.
Ghosh, AK; Mason, D Y; Spriggs, A I (1983). "Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease". J Clin Pathol. 36 (10): 1150–53. doi:10.1136/jcp.36.10.1150. PMC 498493. PMID 6194182.
Ghosh, AK; Spriggs, AI; Taylor-Papadimitriou, J; Mason, DY (1983). "Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies". J Clin Pathol. 36 (10): 1154–64. doi:10.1136/jcp.36.10.1154. PMC 498494. PMID 6194183.
Vissers, CJ; Flohil, CC; De Jong, AA; Dinjens, WN; Bosman, FT (1996). "A new monoclonal antibody for specific immunocytochemical staining of nucleoli". Acta Histochemica. 98 (2): 113–21. doi:10.1016/S0065-1281(96)80028-6. PMID 8739296.

nih.gov

pubmed.ncbi.nlm.nih.gov

Milstein, C (1999). "The hybridoma revolution: an offshoot of basic research". BioEssays. 21 (11): 966–73. doi:10.1002/(SICI)1521-1878(199911)21:11<966::AID-BIES9>3.0.CO;2-Z. PMID 10517870.
Nelson, PN; Reynolds, GM; Waldron, EE; Ward, E; Giannopoulos, K; Murray, PG (2000). "Demystified ...: Monoclonal antibodies". Molecular Pathology. 53 (3): 111–7. doi:10.1136/mp.53.3.111. PMC 1186915. PMID 10897328.
Korbakis, D; Brinc, D; Schiza, C; Soosaipillai, A; Jarvi, K; Drabovich, AP; Diamandis, E (2015). "Immunocapture-selected reaction monitoring screening facilitates the development of ELISA for the measurement of native TEX101 in biological fluids". Molecular & Cellular Proteomics. 14 (6): 1517–1526. doi:10.1074/mcp.M114.047571. PMC 4458717. PMID 25813379.
Phung, Yen; Gao, Wei; Man, Yan-Gao; Nagata, Satoshi; Ho, Mitchell (September 2012). "High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening". mAbs. 4 (5): 592–599. doi:10.4161/mabs.20933. ISSN 1942-0870. PMC 3499300. PMID 22820551.
Bretton, PR; Melamed, MR; Fair, WR; Cote, RJ (1994). "Detection of occult micrometastases in the bone marrow of patients with prostate carcinoma". Prostate. 25 (2): 108–14. doi:10.1002/pros.2990250208. PMID 7518596. S2CID 32801503.
Kvalheim, G (1996). "Detection of occult tumor cells in bone marrow and blood in breast cancer patients—methods and clinical significance". Acta Oncol. 35: 13–18. doi:10.3109/02841869609098516. PMID 9073044.
Kvalheim, G (1998). "Diagnosis of minimal residual disease in bone marrow and blood in cancer patients--methods and clinical implications". Acta Oncologica. 37 (5): 455–62. doi:10.1080/028418698430403. PMID 9831374.
Franklin, WA; Shpall, EJ; Archer, P; Johnston, CS; Garza-Williams, S; Hami, L; Bitter, MA; Bast, RC; Jones, RB (1996). "Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support". Breast Cancer Res Treat. 41 (1): 1–13. doi:10.1007/BF01807031. PMID 8932871. S2CID 37415751.
Riesenberg, R; Oberneder, R; Kriegmair, M; Epp, M; Bitzer, U; Hofstetter, A; Braun, S; Riethmüller, G; Pantel, K (1993). "Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumour cells". Histochemistry. 99 (1): 61–6. doi:10.1007/BF00268022. PMID 7682210. S2CID 8007388.
Ghosh, AK; Mason, D Y; Spriggs, A I (1983). "Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease". J Clin Pathol. 36 (10): 1150–53. doi:10.1136/jcp.36.10.1150. PMC 498493. PMID 6194182.
Ghosh, AK; Spriggs, AI; Taylor-Papadimitriou, J; Mason, DY (1983). "Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies". J Clin Pathol. 36 (10): 1154–64. doi:10.1136/jcp.36.10.1154. PMC 498494. PMID 6194183.
Vissers, CJ; Flohil, CC; De Jong, AA; Dinjens, WN; Bosman, FT (1996). "A new monoclonal antibody for specific immunocytochemical staining of nucleoli". Acta Histochemica. 98 (2): 113–21. doi:10.1016/S0065-1281(96)80028-6. PMID 8739296.

ncbi.nlm.nih.gov

Nelson, PN; Reynolds, GM; Waldron, EE; Ward, E; Giannopoulos, K; Murray, PG (2000). "Demystified ...: Monoclonal antibodies". Molecular Pathology. 53 (3): 111–7. doi:10.1136/mp.53.3.111. PMC 1186915. PMID 10897328.
Korbakis, D; Brinc, D; Schiza, C; Soosaipillai, A; Jarvi, K; Drabovich, AP; Diamandis, E (2015). "Immunocapture-selected reaction monitoring screening facilitates the development of ELISA for the measurement of native TEX101 in biological fluids". Molecular & Cellular Proteomics. 14 (6): 1517–1526. doi:10.1074/mcp.M114.047571. PMC 4458717. PMID 25813379.
Phung, Yen; Gao, Wei; Man, Yan-Gao; Nagata, Satoshi; Ho, Mitchell (September 2012). "High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening". mAbs. 4 (5): 592–599. doi:10.4161/mabs.20933. ISSN 1942-0870. PMC 3499300. PMID 22820551.
Ghosh, AK; Mason, D Y; Spriggs, A I (1983). "Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease". J Clin Pathol. 36 (10): 1150–53. doi:10.1136/jcp.36.10.1150. PMC 498493. PMID 6194182.
Ghosh, AK; Spriggs, AI; Taylor-Papadimitriou, J; Mason, DY (1983). "Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies". J Clin Pathol. 36 (10): 1154–64. doi:10.1136/jcp.36.10.1154. PMC 498494. PMID 6194183.

semanticscholar.org

api.semanticscholar.org

Bretton, PR; Melamed, MR; Fair, WR; Cote, RJ (1994). "Detection of occult micrometastases in the bone marrow of patients with prostate carcinoma". Prostate. 25 (2): 108–14. doi:10.1002/pros.2990250208. PMID 7518596. S2CID 32801503.
Franklin, WA; Shpall, EJ; Archer, P; Johnston, CS; Garza-Williams, S; Hami, L; Bitter, MA; Bast, RC; Jones, RB (1996). "Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support". Breast Cancer Res Treat. 41 (1): 1–13. doi:10.1007/BF01807031. PMID 8932871. S2CID 37415751.
Riesenberg, R; Oberneder, R; Kriegmair, M; Epp, M; Bitzer, U; Hofstetter, A; Braun, S; Riethmüller, G; Pantel, K (1993). "Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumour cells". Histochemistry. 99 (1): 61–6. doi:10.1007/BF00268022. PMID 7682210. S2CID 8007388.

worldcat.org

search.worldcat.org

Phung, Yen; Gao, Wei; Man, Yan-Gao; Nagata, Satoshi; Ho, Mitchell (September 2012). "High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening". mAbs. 4 (5): 592–599. doi:10.4161/mabs.20933. ISSN 1942-0870. PMC 3499300. PMID 22820551.